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Introduction: microRNAs (miRNAs) play important role in the regulation of placental development, and abnor-
mal miRNA expression is associated with preeclampsia (PE). miRNAs are released from trophoblast cells to ma-
ternal blood flow, where they are highly stable, being encapsulated inside extracellular vesicles, like exosomes
or bound to Argonaute proteins. In PE, placental dysfunction leads to aberrant extracellular miRNA secretion.
hsa-miR-210 is a hypoxia-sensitive miRNA found to be upregulated in PE; however, it is unknown whether it is
the cause or the consequence of the disease.
Objective: Our aim was to analyze the expression of several miRNAs, including hsa-miR-210 in placenta, exo-
some and Ago-bound fractions comparing normal (N) and PE pregnancies. We performed in vitro analyses of
extracellular hsa-miR-210 secretion of trophoblast cell cultures (of villous and extravillous origin) under hypoxic
condition.
Methods: PE and N placenta samples were collected from C-sections, and blood samples were drawn from each
pregnant woman in the third trimester. HTR-8 and JAR cell lines were cultured in exosome-free media and
treated with hypoxia-mimetic agents. Exosome and Ago-bound fractions were isolated by membrane affinity spin
column method from plasma and cell media. Short RNAs were extracted from exosomes and vesicle-free frac-
tions, and total-RNA was isolated from the placenta samples. The RNA purity and concentration were measured
by spectrophotometry. Expression analysis was carried out by qPCR with specific primers to target and reference
miRNAs.
Results: The level of hsa-miR-210 was significantly higher in PE placentas, which could cause a minor increase of
exosomal and a high elevation of Ago-bound miR-210 in circulation. Hypoxia leads to intracellular hsa-miR-210
upregulation in trophoblast cell lines. In extravillous cell (HTR-8) media, only the level of exosomal hsa-miR-210
was increased but no change in Ago-bound hsa-miR-210 level was observed. In contrast, in villous cell (JAR)
media, the level of exosomal hsa-miR-210 was increased and enhanced release of Ago-bound hsa-miR-210 was
also observed.
Conclusion: Based on our data, we postulate that in PE, exosomal hsa-miR-210 are secreted actively from the
trophoblast, and by intercellular communication, it may have a role in disease etiology. In addition, there is a
passive release of Ago-bound hsa-miR-210 into the circulation, which may represent by-products of cell-death
and is thereby a possible consequence of the disease.
Abbreviations: miRNAs, microRNAs; PE, preeclampsia; N, normal; EOPE, early-onset preeclampsia; LOPE, late-onset preeclampsia; STB, syncytiotrophoblast; EVs, extracellular vesicles;
HRE, hypoxia-responsive element; HUVEC, Human Umbilical Vein Endothelial Cell; ISCU, iron-sulfur scaffold homologue.
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1. Introduction
1.1. Preeclampsia
Preeclampsia (PE) is of the leading causes of maternal and fetal
morbidity and mortality, affecting 3–8% of all pregnancies around the
world (Duley, 2009). It is a multisystemic pregnancy-specific disorder,
characterized by the development of hypertension and proteinuria after
20weeks of gestation. In the absence of proteinuria, the diagnosis may
be established by the occurrence of other maternal organ failures due to
endothelial dysfunction (Tranquilli et al., 2014).
Although the etiology and pathogenesis of PE are debated, the gen-
erally accepted theory denotes placental malperfusion as the main cause
of the disease. In the case of early-onset preeclampsia (EOPE,
<34weeks), the placental dysfunction is a consequence of the insuffi-
cient extravillous trophoblast invasion and spiral arterial remodeling,
therefore the pathophysiological changes take place well before the clin-
ical manifestations. It has been proposed that in late-onset preeclamp-
sia (LOPE, >34weeks) the placenta exceeds the capacity of the uterus
and its vasculature to comply with the increasing demands in term preg-
nancy, leading to deficient intervillous perfusion and increased hypoxia
(Redman, 2017). In both scenarios, maternal blood flow to the placenta
is hindered and high perfusion pressure constituting shear stress to the
villous trophoblast layer. This phenomenon results in widespread syncy-
tiotrophoblast (STB) damage and subsequent release of toxic materials
including cell fragments, antiangiogenic factors, proinflammatory medi-
ators, and extracellular vesicles (EVs) that are capable of activating the
maternal endothelium.
1.2. Exosomes
EVs are lipid bilayer structures that are secreted from all kinds of
cells into the extracellular space. They comprise proteins, lipids, non-
coding RNAs, and other regulatory elements. EVs are distinguished by
size, function, biogenesis, and morphology into three categories: mi-
crovesicles, apoptotic bodies, and exosomes. Exosomes are the smallest
of EVs with a size between 40 and 120nm (Kowal et al., 2014). The
level and content of placenta-specific exosomes may provide useful in-
formation on placental health. In the course of physiologically normal
pregnancy, EVs are continuously shed from the STB into the maternal
circulation. The release of these particles rises with gestation as the pla-
centa grows in size, and returns to non-pregnant levels in 48h after de-
livery (Salomon et al., 2014a).
After secretion from cells, exosomes may have a function in intercel-
lular communication. Over the last decade, several in vitro studies have
been carried out investigating the effect of placental vesicles on differ-
ent target cells (Salomon et al., 2014a, 2014b, 2013a, 2013b; Truong
et al., 2017). It was demonstrated that they are capable of modulat-
ing the activity of adjacent cells, which may play a role in the progres-
sion and maintenance of physiological pregnancy. However, pathologi-
cal processes can change the number and composition of vesicles, which
may lead to the development of various pregnancy complications. In PE,
the excessive shear stress resulting from abnormal placentation leads to
morphological damage and increased shedding of STB, which may con-
tribute to generalized endothelial dysfunction.
1.3. Placental and cell-free miRNAs
miRNAs are endogenous, 20–22 nucleotides long, non-coding RNA
molecules, which play important role in the post-transcriptional regu-
lation of gene expression by either repressing protein translation or in
ducing mRNA degradation. They are involved in fundamental biological
process, such as cell proliferation, differentiation, apoptosis and have
been linked to the pathogenesis of several human diseases (Gebert and
MacRae, 2018; Li and Kowdley, 2012).
Several hundred miRNAs are expressed by different layers of the hu-
man placenta; however, their function in pregnancy is not fully eluci-
dated. miRNAs take part in the regulation of placental development, and
abnormal miRNA expression is associated with pregnancy complications
including PE (Fu et al., 2013). miRNAs are released from trophoblast
cells to maternal blood flow, where they are highly stable, being encap-
sulated inside extracellular vesicles (like exosomes) or bound to stabi-
lizing proteins (mainly Argonaute proteins) (Ouyang et al., 2014). Cells
seem to selectively release certain non-coding RNAs, thereby affecting
the function of surrounding and distant target cells. Exosomal miRNAs
can be internalized by recipient cells, where they mediate functional ef-
fects by altering host gene expression (Valadi et al., 2007). The miRNA
expression patterns of the source cell and released exosomes are usu-
ally different, which supports the idea of active exosomal miRNA sort-
ing. However, exosomal miRNAs constitute only a minor fraction of the
whole plasma miRNA population, the majority of which are Ago-bound
miRNAs (Turchinovich et al., 2011). Non-vesicular miRNAs are believed
to be non-specific by-products of general physiological processes and
cell death, however, their significance is not known (Schwarzenbach et
al., 2014). It has been proposed that vesicle- versus Ago complex-as-
sociated miRNAs originate from different cell types and reflect cell
type-specific miRNA expression and/or release mechanisms (Arroyo et
al., 2011). Ago-specific miRNA profile in blood cells and in the whole
plasma differs significantly indicating that most circulating non-vesicu-
lar miRNAs are likely to be derived from non-blood cells (Turchinovich
and Burwinkel, 2012).
1.4. hsa-miR-210 hypoxamiR
In PE, deficient trophoblast invasion and spiral arterial remodeling
lead to prolonged placental hypoxia. hsa-miR-210 is a hypoxia-induced
miRNA and considered as one of the hallmarks of hypoxic responses in
several cell types, including trophoblast and endothelial cells (Chan and
Loscalzo, 2010). HIF-1α is directly recruited to the hypoxia-responsive
element (HRE) in the hsa-miR-210 promoter region and triggers miRNA
transcription (Huang et al., 2010, 2009).
The direct effect of the elevated hsa-miR-210 level on pregnancy is
currently unknown. In our previous study, we have created a miRNA
regulated interaction network by the integration of available miRNA
and gene expression profiles in preeclampsia, and hsa-miR-210 was the
highest degree node in the network (Biró et al., 2017a). It has been as-
sociated with preeclampsia before (Sheikh et al., 2016), however, it is
questionable whether it is the cause or the consequence of the disease.
The mode of miRNA secretion (exosomal or Ago-bound) and the signifi-
cance of the different forms are not clarified either. In this study, we hy-
pothesized that extracellular hsa-miR-210 profile differs in PE and nor-
mal pregnancy which could be the result of abnormal placental miRNA
expression and secretion in case of PE.
Our aim was to analyze the expression of hsa-miR-210 in placenta,
exosome and Ago-bound fractions comparing PE and N pregnancies.
Apart from hsa-miR-210, the expression of hsa-miR-16 and
hsa-miR-517c was also measured and used for comparison. hsa-miR-16
is one of the most abundant miRNAs in blood, found to be expressed
mainly by red blood cells (Pritchard et al., 2012). hsa-miR-517c is part
of the primate-specific C19MC miRNA cluster, which is abundantly ex-
pressed in the placenta (Noguer-Dance et al., 2010). We performed an in
vitro analysis of extracellular miRNA secretion of different trophoblast
cell cultures under normoxic and hypoxic conditions.
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2. Materials and methods
2.1. Study participants
Study participants had been recruited during routine prenatal care
or following hospital admission during the third trimester of pregnancy
at 1st Department of Obstetrics and Gynecology, Semmelweis Univer-
sity, Budapest, Hungary. In this study 16 plasma and 20 placenta sam-
ples were included, 8 vs. 8 and 13 vs. 7 preeclamptic (PE) and nor-
mal (N) cases respectively. Inclusion criteria for the PE group were
blood pressure>140/90mmHg with proteinuria>300mg/24h or at
least 1g/L (++) on dipstick testing. Pregnancies with ongoing labour,
multiple gestations, and congenital malformations were not included.
In the normotensive group, exclusion criteria also included the history
of pregnancy-related or other forms of hypertension, spontaneous abor-
tion, preterm birth, and intrauterine growth restriction. Placenta sam-
ples were collected from C-sections and blood samples were drawn from
each pregnant woman in the third trimester.
The study protocol was approved by the Scientific and Research
Ethics Committee of the Medical Research Council (ETT TUKEB) [No:
24387-2/2016] and written informed consent was obtained from each
patient. The research was conducted in accordance with the Declaration
of Helsinki.
2.2. Sample collection and handling
Venous blood samples were collected into 4mL EDTA tubes and
kept at 4 °C until processing. Plasma was separated within few hours by
two-step centrifugation (1. 2500g, 10min, 4 °C, 2. 12,500g, 10min, 4 °C)
and stored in 1.5ml Eppendorf tubes at −80 °C.
Placenta samples were collected according to the protocol described
by Pasupathy et al. (2008). Four areas suitable for sampling were lo-
cated on the maternal surface; damaged areas not suitable for further ex-
amination (calcification, hematoma, etc.) were excluded. 1–2mm from
the basal membrane was removed and a pea size tissue sample was
taken from the placental cotyledons. The samples were washed twice in
1× PBS solution at 4 °C and placed in RNAlater (Thermo Fisher Scien-
tific) stabilizing solution to avoid RNA degradation.
2.3. Cell culture and treatment
We used JAR and HTR-8 placenta-derived cell lines. The former is
a choriocarcinoma cell line and has the characteristics of villous tro-
phoblasts (VT), while the latter one is an immortalized extravillous tro-
phoblast (EVT) cell line.
JAR and HTR-8 cell lines were maintained under standard condi-
tions at 37 °C and 5% CO⁠2 in RPMI-1640 (Gibco) or DMEM (Gibco)
medium respectively, supplemented with 10% FBS (Gibco) and 1%
penicillin-streptomycin. 4×10⁠5 cells were seeded per well on six-well
plates in media containing 10% exosome-depleted FBS. Cells were
treated after 24h with hypoxia-mimetic agent (100μM DFO or 50μM
DFX), or DMSO as control and maintained under standard conditions
for another 24h. DFO and DFX are well-known iron chelators used for
modeling hypoxic conditions in cell cultures.
2.4. Total-RNA and miRNA isolation
Exosomes were isolated from plasma and cell media using the Ex-
oRNEasy kit, which applies membrane affinity spin column method (Qi-
agen). As compared to ultracentrifugation, this method is faster and
yields a cleaner preparation of exosomes (Enderle et al., 2015). Exo
somes were bound to the column membrane and protein complexes
were partitioned to the flow-through. Short RNAs were extracted from
exosomes and vesicle-free fractions.
Total-RNA was isolated from the placenta samples and cultured tro-
phoblast cell lines using the TRIzol™ lysis reagent (Thermo Fisher Sci-
entific) according to the manufacturer's protocol. The RNA purity and
concentration were measured by Nanodrop spectrophotometer (Thermo
Fisher Scientific).
2.5. Expression analysis
The expression analysis was performed using the miRCURY LNA™
Universal RT miRNA PCR Assay (Qiagen) according to the manufac-
turer's instructions. Briefly, RNA samples (5ng/μl) were reverse-tran-
scribed using the miRCURY LNA™ RT Kit. UniSp6 RNA spike-in tem-
plate was added to each reaction for cDNA synthesis control. cDNAs
of placental and cell culture RNAs were 1:80 diluted, while templates
from exosomal and Ago-bound miR fractions were 1:10 diluted be-
fore subsequent amplification. RT-PCR was carried out using miRCURY
SYBR® Green master mix with specific LNA™ PCR primer sets, run on
a StepOnePlus™ platform (Thermo Fisher Scientific) using the manu-
facturer's instructions. The relative expression of the investigated miR-
NAs was calculated based on the ΔΔCT method and was normalized to
hsa-miR-103a internal control miRNA. The miRBase identifiers and seed
sequences of investigated and reference miRNAs are listed in Table 1.
Melting curve analysis was carried out following each PCR run for eval-
uating the specificity of the assays.
2.6. Statistics
We used the STATISTICA software package (Statistica, Tulsa, Okla-
homa, USA) for statistical analysis. Shapiro-Wilk W test was applied to
assess the normality of the dependent variables. None of the miRNA ex-
pression values of placenta and plasma samples followed a normal dis-
tribution, thus comparisons between groups were performed using the
nonparametric Mann-Whitney U test and exact probabilities were cal-
culated. The data were represented on box plots, where miRNA levels
were shown as median with interquartile ranges. The miRNA expression
values of cell culture were logarithmized and one-sided t-test was ap-
plied. The data were represented on barplots, where the untransformed
miRNA levels were shown as mean with standard error. A p value of
<0.05 considered as a statistically significant finding.
3. Results
3.1. Patient characteristics
In the first part of the study, we analyzed the expression of
hsa-miR-210 in placenta, exosome and Ago-bound plasma fractions
comparing PE and N pregnancies. 16 plasma and 20 placenta samples
were included, 8 vs. 8 and 13 vs. 7 PE and N cases respectively. The
patient characteristics of the collected plasma and placenta samples are
summarized in Tables 2 and 3.
Table 1
Investigated and reference miRNAs.
miRNA name mirBase identifier Seed sequence
hsa-miR-210-3p MIMAT0000267 5′-CUGUGCGUGUGACAGCGGCUGA-3′
hsa-miR-16-5p MIMAT0000069 5′-UAGCAGCACGUAAAUAUUGGCG-3′
hsa-miR-517c-3p MIMAT0002866 5′-AUCGUGCAUCCUUUUAGAGUGU-3′
hsa-miR-103a-3p MIMAT0000101 5′-AGCAGCAUUGUACAGGGCUAUGA-3′
3
UN
CO
RR
EC
TE
D
PR
OO
F
O. Biró et al. Gene xxx (2019) xxx-xxx
Table 2
Patient characteristics of plasma samples.Values are given as mean with standard
deviation. N: Normal group, PE: Preeclamptic group.
N PE
p-
Value
n 8 8
Gestational age at
sampling (weeks)
36,13±3,00 31,00±5,07 <0,05
Gestational age at birth
(weeks)
37,38±1,85 31,13±5,17 <0,05
Birth weight (g) 3313,75±569,69 1798,29±1254,50 <0,05
Maternal age (years) 31,25±5,80 33,43±6,48 >0,05
Table 3
Patient characteristics of placenta samples.Values are given as mean with standard
deviation. N: Normal group, PE: Preeclamptic group.
N PE
p-
Value
n 7 13
Gestational age at birth
(weeks)
38,14±0,69 30,39±4,59 <0,05
Birth weight (g) 3446,67±525,23 1529,00±990,75 <0,05
Maternal age (years) 30,29±6,16 33,67±5,43 >0,05
3.2. Placental and extracellular hsa-miR-210 expression
The level of placental hsa-miR-210 was significantly upregulated in
affected samples comparing to the control group (Fig. 1A), which could
be related to a minor increase of circulating exosomal (Fig. 1B) and
significantly elevated Ago-bound hsa-miR-210 (Fig. 1C). We found that
hsa-miR-210 was overrepresented in the Ago-bound fraction compared
to exosomal fraction in the PE but not in the N group.
The level of placental hsa-miR-517c was significantly upregulated in
affected samples comparing to the control group (Fig. 2A), but there
was no significant difference in the level of extracellular hsa-miR-517c
between groups (Fig. 2B, C). Neither the level of placental hsa-miR-16
(Fig. 3A) nor extracellular hsa-miR-16 was altered due to PE (Fig.
3B, C).
3.3. In vitro hsa-miR-210 secretion from trophoblast cell-lines
In the second part of the study, we performed an in vitro analysis of
extracellular hsa-miR-210 secretion of different trophoblast cell cultures
under normoxic and hypoxic conditions.
3.3.1. Effect of hypoxia on JAR cells and secreted cell-free miRNAs
The treatment of villous trophoblast cells with hypoxia-mimetic
agent selectively upregulated hsa-miR-210 as compared to the other ex-
amined miRNA species (Fig. 4A). In the cell media, the level of exoso-
mal hsa-miR-210 was significantly increased and enhanced release of
Ago-bound miRNAs was also observed (Fig. 4B, C). There was no signif-
icant difference in the case of hsa-miR-16, and hsa-miR-517c.
3.3.2. Effect of hypoxia on HTR-8 cells and secreted cell-free miRNAs
The treatment of the extravillous trophoblast cells with hy-
poxia-mimetic agent strongly upregulated hsa-miR-210 (Fig. 5A), and
this phenomenon was even more pronounced in secreted exosomal sam-
ples: only the level of exosomal hsa-miR-210 was increased (Fig. 5B)
and a no significant change on Ago-bound hsa-miR-210 level was ob-
served (Fig. 5C). There was no significant difference in the case of
hsa-miR-16 and hsa-miR-517c is not expressed in this cell line.
4. Discussion
Exosomes have been shown to be capable of modulating the activ-
ity of adjacent cells, which may play a role in the development and
maintenance of physiological pregnancy. Over the last decade, several
in vitro studies have been carried out investigating the effect of placen-
tal vesicles on different target cells. Salamon et al. demonstrated that
Fig. 1. Placental (A), exosomal (B), and Ago-bound (C) hsa-miR-210 expression in N vs. PE group.miRNA levels are shown as median with interquartile ranges, *: p<0.05, **: p<0.01.
Fig. 2. Placental (A), exosomal (B), and Ago-bound (C) hsa-miR-517c expression in N vs. PE group.miRNA levels are shown as median with interquartile ranges, *: p<0.05.
4
UN
CO
RR
EC
TE
D
PR
OO
F
O. Biró et al. Gene xxx (2019) xxx-xxx
Fig. 3. Placental (A), exosomal (B), and Ago-bound (C) hsa-miR-16 expression in N vs. PE group.miRNA levels are shown as median with interquartile ranges.
Fig. 4. Intracellular (A), exosomal (B), Ago-bound (C) miRNA expression in JAR cells in hypoxia.Untransformed miRNA levels are shown as mean with standard error, *: p<0.05.
Fig. 5. Intracellular (A), exosomal (B), Ago-bound (C) miRNA expression in HTR8 cells in hypoxia.Untransformed miRNA levels are shown as mean with standard error, *: p<0.05.
EVT exosomal signaling may contribute to spiral artery remodeling by
enhancing the migration of vascular smooth muscle cells out of the
vessel walls. They propose that during a normal placentation, EVT-de-
rived exosomes that contain specific regulatory molecules (e.g. miR-
NAs) promote loss of vascular cells facilitating remodeling of the spi-
ral uterine arteries (Salomon et al., 2014b). The same group investi-
gated the bioactivity of circulating placental exosomes and they found
that treating HUVEC (Human Umbilical Vein Endothelial Cell) culture
with these vesicles increases endothelial cell migration. Importantly, the
bioactivity of exosomes was the greatest in the first trimester and de-
creased with the progression of pregnancy. Their results indicate that
in a healthy pregnancy, trophoblast-derived exosomes may facilitate
the maternal vascular adaptation to pregnancy (Salomon et al., 2013a).
They have also shown that in response to changes in oxygen tension,
cytotrophoblast cells modify the bioactivity and protein-content of the
secreted exosomes, which were able to alter EVT phenotype. Exosomal
induction of EVT migration may represent an adaptive response to pla-
cental hypoxia in the first trimester (Salomon et al., 2013b).
Pathological processes may change the number and composition of
vesicles, which may lead to the development of various pregnancy dis-
orders. In PE, the presence of extensive hypoxia and accumulated proin-
flammatory cytokines (e.g. TNF-α) may inhibit the beneficial effect of
exosomes on vascular cell migration leading to inadequate arterial re-
modeling. Truong et al. showed that the level of exosomes secreted
by EVTs is significantly higher at 1% O⁠2 than 8% O⁠2. Exosomes iso-
lated from EVT cells cultured in normoxia contained miRNAs linked
with cell migration, while exosomes isolated from EVT cultured in hy-
poxia had miRNAs associated with inflammatory response and regula-
tion of cytokine production. They conclude that oxygen tension mod-
ifies the effect of EVT-derived exosomes on endothelial cells, thereby
hypoxic condition inhibits EVT migration out of the artery and in-
creases the concentration of TNFα at the site of remodeling. Abnormal
EVT function may result in compromised placental perfusion and pro
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longed hypoxia leading to pregnancy complications (Truong et al.,
2017).
The placental dysfunction causes the enhanced shedding of tro-
phoblast-derived EVs into the maternal circulation, which may provoke
drastic biological changes systemically. There is a growing evidence for
STB EV's function in the immunological adaptations to pregnancy. Their
role in the activation of the innate immune system has been indicated
by that monocytes can bind and internalize STB EVs. As a result, mono-
cytes start producing various cytokines, such as TNF-α, and IL-1β. Based
on data from in vitro studies, it can be suggested that STB EVs may sup-
port the exaggerated inflammatory state observed in preeclamptic preg-
nancies (Göhner et al., 2017).
We investigated placental, exosomal and Ago-bound hsa-miR-210
expression profile in PE vs. N groups. The level of hsa-miR-210 was
significantly higher in PE placentas, which could be associated with a
minor increase of circulating exosomal, and highly elevated Ago-bound
hsa-miR-210. In our former study, we found that the concentration of
total-miRNA and exosomal hsa-miR-210 was significantly higher in the
circulation of women affected by PE (Biró et al., 2017b). The difference
in the exosomal expression levels could be due to the different sample
numbers and exosome isolation techniques applied it the two studies.
It has been shown that hsa-miR-210 is expressed by several parts
of the cardiovascular system (Chan et al., 2012), thus it may be also
a potential surface for releasing hsa-miR-210 into the maternal circu-
lation. Similarly to the placenta, cancer cells actively release exosomes
carrying specific regulatory and signaling molecules to communicate
with various cells in the tumor microenvironment. Jung et al. visualized
exosome-mediated transfer of hsa-miR-210 from hypoxic breast cancer
cells to neighboring cells using a specific reporter system. They found
that exosomal hsa-miR-210 was transferred to cells in the tumor milieu,
where it regulated the expression of vascular remodeling related genes
to promote angiogenesis. These results demonstrated well that in can-
cer, particular cellular miRNAs are secreted and transferred to proximal
cells via exosomes and through this mechanism, they are able to influ-
ence tumor progression (Jung et al., 2017). Hale et al. proposed that the
Argonaute 2-dependent control of released hsa-miR-210 is also possi-
ble and it synchronizes the hypoxic response in different cell-types, pre-
venting redundant activity of delivered hsa-miR-210 in normoxia while
potentiating the adaptation of recipient tissues to hypoxic stress. They
demonstrated that released hsa-miR-210 can be transferred to recipi-
ent cells, where it downregulates the mitochondria-associated iron-sul-
fur scaffold homologue (ISCU), thereby suppressing mitochondrial me-
tabolism (Hale et al., 2014).
We performed an in vitro analysis of extracellular hsa-miR-210 se-
cretion of different trophoblast cell cultures under normoxic and hy-
poxic conditions. Hypoxia-induction had a different effect on the villous
and extravillous trophoblast cell lines. The intracellular hsa-miR-210
was upregulated in both cases, however, in extravillous cell media, only
the level of exosomal hsa-miR-210 was increased and a no change on
Ago-bound hsa-miR-210 level was observed. Therefore, in this case, hy-
poxia resulted in the specific exosomal sorting of hsa-miR-210 – as this
cell type has a role in trophoblast invasion, this phenomenon may have
a role in placental dysfunction. In villous cell media, the level of exo-
somal hsa-miR-210 was increased and enhanced release of Ago-bound
hsa-miR-210 was also observed. The expression profile was quite simi-
lar to that of the placenta and plasma samples – which can be explained
by the fact in placenta this cell type is in contact with maternal cir-
culation. Based on these data, we suggest the use of JAR trophoblast
cell-line for modeling mature placenta physiology and function, while
the HTR-8 trophoblast cell-line is more appropriate for the investigation
of placenta development and pathogenesis of associated diseases.
The hypoxia-induced hsa-miR-210 regulates numerous biological
processes both in physiological and pathogenic circumstances. It is
overexpressed in most solid tumors, and its levels correlate with a neg-
ative clinical outcome. Several genes have been experimentally vali-
dated and even more were predicted as targets of hsa-miR-210. These
genes play important roles in various cellular processes such as prolif-
eration, apoptosis, differentiation, angiogenesis, and metabolism. Ele-
vated levels of hsa-miR-210 may lead to placental mitochondria dys-
function and oxidative stress by the repression of ISCU (Lee et al., 2011).
Supporting its pathogenic role, the targeted mRNA was significantly
reduced with concomitant hsa-miR-210 overexpression in preeclamp-
tic placenta samples (Muralimanoharan et al., 2012). Ishibashi et al.
showed that hsa-miR-210 regulates 17-beta-hydroxysteroid dehydro-
genase (HSD17B1), a steroidogenic enzyme expressed predominantly
in the placenta. The plasma HSD17B1 protein levels, as well as the
placental expression, were decreased in preeclamptic pregnant women
(Ishibashi et al., 2012). Ephrin-A3 (EFNA3) and Homeobox-A9
(HOXA9) are also validated targets of hsa-miR-210, EFNA3 is a key reg-
ulator of vascularization and cell migration, while HOXA9 plays an im-
portant role in angiogenesis (Fasanaro et al., 2008; Zhang et al., 2012).
Anton et al. demonstrated that overexpressing hsa-miR-210 reduces tro-
phoblast invasion and vice versa, hsa-miR-210 inhibition promotes inva-
sion. Moreover, they conclude that it may help to identify at-risk women
for monitoring and treatment since elevated first-trimester serum
hsa-miR-210 expression was predictive of the disease (Anton et al.,
2013). All of the referred mechanisms regulated by hsa-miR-210 are as-
sociated with the development of PE, including disturbed trophoblast
invasion, and oxidative stress.
5. Conclusions
We investigated placental, exosomal and Ago-bound hsa-miR-210
expression profile in PE vs N groups. The level of hsa-miR-210 was
significantly higher in PE placentas, which could be related to a mi-
nor increase of circulating exosomal and highly elevated Ago-bound
hsa-miR-210. The hypoxia-induction had a different effect on the vil-
lous and extravillous trophoblast cell lines: intracellular hsa-miR-210
was upregulated in both cases, however, in extravillous cell media, only
the level of exosomal hsa-miR-210 was increased and a no change on
Ago-bound hsa-miR-210 level was observed. Therefore, in this case, hy-
poxia resulted in the specific exosomal sorting of hsa-miR-210 – as this
cell type has a role in trophoblast invasion, this phenomenon may have
a role in placental dysfunction. In villous cell media, the level of exo-
somal hsa-miR-210 was increased and enhanced release of Ago-bound
hsa-miR-210 was also observed. The expression profile was quite similar
to that of the placenta and plasma samples which can be explained by
the fact that in placenta this cell type is in contact with maternal circu-
lation.
Based on our results, we postulate that in PE, exosomal hsa-miR-210
is secreted actively from the trophoblast, which may have a role in in-
tercellular communication and play a role in disease etiology. Moreover,
there is also a passive release of Ago-bound hsa-miR-210, which could
be the by-product of cell-death and so it is a possible consequence of the
disease.
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